Author:
Kok Beverley, ,Lester Erica L. W.,Lee William M.,Hanje A. James,Stravitz R. Todd,Girgis Safwat,Patel Vaishali,Peck Joshua R.,Esber Christopher,Karvellas Constantine J.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference30 articles.
1. Bezabeh S, Flowers CM, Kortepeter C, Avigan M. Clinically significant liver injury in patients treated with natalizumab. Aliment Pharmacol Ther. 2010;31:1028–1035.
2. FDA. Briefing document: Arthritis Advisory Committee., City.
http://www.fda.gov/ohrms/dockets/ac/03/transcripts/3930T1.htm;2003
3. Ghabril M, Bonkovsky HL, Kum C, et al. Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol.. 2013;11:558–564.e553.
4. Lee WM. Drug-induced acute liver failure. Clin Liver Dis. 2013;17:575–586, viii.
5. Reddy KR, Ellerbe C, Schilsky M, et al. Determinants of outcome among patients with acute liver failure listed for liver transplantation in the US. Liver Transpl. 2015;22:505–515.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献